NYSE:ITGR • US45826H1095
The current stock price of ITGR is 84.03 USD. Today ITGR is down by -1.41%. In the past month the price decreased by -1.41%. In the past year, price decreased by -31.1%.
ChartMill assigns a technical rating of 2 / 10 to ITGR. When comparing the yearly performance of all stocks, ITGR is a bad performer in the overall market: 73.48% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to ITGR. ITGR has an average financial health and profitability rating.
On February 19, 2026 ITGR reported an EPS of 1.76 and a revenue of 472.06M. The company beat EPS expectations (1.59% surprise) and beat revenue expectations (0.02% surprise).
17 analysts have analysed ITGR and the average price target is 94.13 USD. This implies a price increase of 12.02% is expected in the next year compared to the current price of 84.03.
For the next year, analysts expect an EPS growth of 0.18% and a revenue growth -0.11% for ITGR
Over the last trailing twelve months ITGR reported a non-GAAP Earnings per Share(EPS) of 6.41. The EPS increased by 20.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.55% | ||
| ROA | 3.01% | ||
| ROE | 5.89% | ||
| Debt/Equity | 0.69 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.08 | 193.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.96 | 176.393B | ||
| SYK | STRYKER CORP | 24.11 | 141.687B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.37 | 108.246B | ||
| IDXX | IDEXX LABORATORIES INC | 41.06 | 49.421B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.46 | 48.681B | ||
| BDX | BECTON DICKINSON AND CO | 10.61 | 48.418B | ||
| RMD | RESMED INC | 20.59 | 37.195B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.79 | 35.143B | ||
| DXCM | DEXCOM INC | 26.97 | 27.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.99 | 18.52B | ||
| PODD | INSULET CORP | 37.39 | 16.95B | ||
| HOLX | HOLOGIC INC | 15.05 | 16.91B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The company is headquartered in Plano, Texas. The company went IPO on 2000-09-29. The firm serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
INTEGER HOLDINGS CORP
5830 Granite Parkway., Suite 1150
Plano TEXAS 75024 US
CEO: Joseph W. Dziedzic
Employees: 11000
Phone: 12146185243
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The company is headquartered in Plano, Texas. The company went IPO on 2000-09-29. The firm serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
The current stock price of ITGR is 84.03 USD. The price decreased by -1.41% in the last trading session.
ITGR does not pay a dividend.
ITGR has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
17 analysts have analysed ITGR and the average price target is 94.13 USD. This implies a price increase of 12.02% is expected in the next year compared to the current price of 84.03.
INTEGER HOLDINGS CORP (ITGR) has a market capitalization of 2.89B USD. This makes ITGR a Mid Cap stock.